Intake Management

Every signal.
Any source.

Adverse events do not only arrive by fax. Vigintake monitors scientific literature, social media, e-commerce platforms, patient support interactions, and internal communications, transforming unstructured signals from any origin into structured, submission-ready ICSR cases.

Explore sources ↓
15+
Integrated data sources
40+
Languages processed
< 2 min
From signal to structured case
100%
Unstructured data covered

The Challenge

Safety signals surface in places most systems cannot reach

Patients report adverse experiences in product reviews, social media posts, forum threads, and support calls, not only in structured MedWatch forms. Without systematic monitoring of these sources, meaningful safety signals go undetected and regulatory obligations go unmet.

Blind spots in monitoring

Traditional pharmacovigilance systems monitor structured channels only. The majority of patient-reported experiences now occur in unstructured digital environments.

Manual review at scale

Manually screening thousands of social media posts, reviews, and literature articles each week is not operationally sustainable with finite safety team resources.

Regulatory exposure

Regulators expect companies to monitor all sources where product-related adverse events may be reported. Gaps in digital surveillance constitute a compliance risk.

Literature Monitoring

Global scientific literature, continuously screened

Vigintake connects to the major biomedical literature databases and monitors newly published articles for relevant safety information on a daily basis. Identified case reports and signals are automatically extracted, assessed for reportability, and routed into the case processing workflow.

Global literature monitoring is available now. Local and regional literature sources are in active development and will follow shortly.

  • PubMed and MEDLINE continuous indexing
  • Embase and global biomedical journals
  • Preprint servers and conference abstracts
  • Automated ICMJE-compliant relevance screening
  • Duplicate and cross-reference detection
  • Regulatory-aligned monitoring frequency
PubMed
25M+ biomedical citations
Embase
Elsevier pharmacology index
MEDLINE
NLM indexed journals
Preprints
bioRxiv · medRxiv · SSRN

Public Digital Sources

Monitoring the open web where patients speak freely

Patients and caregivers share their experiences with medicines and medical products across dozens of public platforms. Vigintake systematically monitors these channels, screening content for reportable adverse events and product quality complaints.

Social Media

Public posts, comments, and threads mentioning medicines or medical products are screened for case-qualifying adverse event language.

X (Twitter) Facebook Instagram LinkedIn Reddit TikTok

E-Commerce Reviews

Product reviews for OTC medicines, supplements, and medical devices frequently contain adverse event reports, product complaints, and packaging concerns.

Amazon eBay Walmart iHerb Vitacost Other OTC retailers

Review Platforms

Patient reviews of healthcare providers, pharmacies, and medical products often contain first-hand reports of unexpected treatment outcomes.

Google Maps Trustpilot Yelp Drugs.com WebMD reviews Healthgrades

Health Communities

Condition-specific communities generate rich, detailed patient narratives that frequently contain spontaneous adverse event reports of high clinical value.

PatientsLikeMe Inspire.com DailyStrength Crohn's forums Condition-specific communities

News & Online Media

Published media containing safety-relevant information about medicinal products may trigger regulatory reporting obligations under GVP guidelines.

Online news articles Medical newsletters Press releases Company announcements Blog publications

App Store Reviews

Reviews of digital health products and connected device companion applications may contain adverse event reports linked to device malfunction or treatment interaction.

Apple App Store Google Play Connected device apps Digital therapeutics mHealth companion apps

Private Enterprise Sources

Connecting to the data your organisation already holds

Much of the most clinically significant safety information flows through internal systems: support call transcripts, medical information enquiries, and company-managed patient forums. Vigintake integrates directly with these private sources, with no manual export required.

Email Integration

Direct connection to your medical information or safety mailbox. Vigintake automatically screens incoming emails for case-qualifying content and extracts ICSR data without any manual triage.

Microsoft 365 Google Workspace IMAP / SMTP Shared mailboxes

PSP Call Transcription

Patient Support Program calls are transcribed and screened automatically. Vigintake identifies reportable adverse events within call recordings and routes them into the case workflow in near real time.

Call transcription PSP platforms Medical information lines Nurse hotlines

Private Forums & Portals

Company-managed patient or HCP portals, closed community forums, and website contact forms are monitored continuously, ensuring that no reportable communication is missed.

Company portals HCP forums Patient communities Web contact forms

How It Works

From raw signal to structured case in minutes

01

Monitor

Vigintake continuously monitors all connected sources, public and private, around the clock, across all configured languages and geographies.

02

Screen

AI classifies each piece of content against reportability criteria: does it contain a suspect product, an adverse event, an identifiable patient, and a reporter?

03

Extract

Qualifying signals are parsed and all ICSR-relevant fields are extracted: product name, reaction terms, patient details, and reporter information.

04

Route

Structured cases enter the processing workflow with MedDRA coding, narrative draft, and triage classification ready for medical review and submission.

Who It's For

Designed for the teams responsible for patient safety

Contract Research Organisations & Service Providers

Managing digital surveillance across multiple clients and product portfolios requires a scalable, configurable platform. Vigintake's multi-tenant architecture allows per-client source configuration, keyword sets, and reporting thresholds.

  • Per-client source and keyword configuration
  • Consolidated and client-separated dashboards
  • Audit-ready monitoring logs per product
  • Scales to any case volume without added headcount

Biotechs & Emerging Pharma

Comprehensive digital surveillance used to require dedicated teams and enterprise contracts. Vigintake makes it accessible from day one, with pre-configured source monitoring for the most common channels and simple activation for additional sources.

  • Rapid deployment: monitoring active within days
  • Pre-built source configurations for standard channels
  • Cloud-native, no IT integration required
  • Pay-as-you-scale pricing model

Get Started

No signal should go undetected.

See how Vigintake monitors your configured sources and surfaces a reportable adverse event in under 3 minutes, live, using your own product data.